Abstract nr
Paediatric Oncology
Proffered Paper Session: Paediatric Oncology
Chair: S. Bielack (Germany)
Chair: M.G. Valsecchi (Italy)
11:30
1400
Prognostic significant copy number variations (CNVs) defined by MLPA in primary and relapsed neuroblastomas (NB)
Speaker: A. Druy (Russian Federation)
11:45
1401
Metronomic topotecan causes a favorable type of therapy-induced-senescence and prolongs survival in MYCN amplified neuroblastoma xenografts
Speaker: S. Taschner-Mandl (Austria)
12:00
1402
Design of the Myechild trial, an international randomised phase III clinical trial in children with acute myeloid leukaemia incorporating an embedded dose finding study
Speaker: K. Wheatley (United Kingdom)
12:15
1403
Pharmacokinetics and pharmacodynamics study of lipegfilgrastim (XM22) in children with Ewing family of tumors or rhabdomyosarcoma
Speaker: M. Belogurova (Russian Federation)
12:30
1404
Calibrated integrated backscatter as a marker of myocardial fibrosis and left ventricular diastolic function in adult survivors of childhood leukaemias
Speaker: V.W.y. Li (Hong Kong)
12:45
1405
Burnout of parents having children with cancer
Speaker: M.E. Samardakiewicz (Poland)